01.07.2014 03:08:00

Brasil Pharma S.A. -- Moody's downgrades Brasil Pharma's ratings to B1/Baa3.br from Ba3/A2.br; outlook revised to negative from stable

Sao Paulo, June 30, 2014 -- Moody's América Latina has downgraded Brasil Pharma's corporate family ratings to B1/Baa3.br from Ba3/A2.br. At the same time, Moody's revised the ratings outlook to negative from stable.

Vollständigen Artikel bei Moodys lesen